Nov 26, 2025 · Keytruda (pembrolizumab) is a PD-1 inhibitor used to treat multiple cancers, including melanoma, lung cancer, breast cancer, and more. Learn about how it works, FDA …

Aug 21, 2025 · Keytruda is a brand-name infusion approved to treat several types of cancer. Learn about side effects, warnings, dosage, and more.

Pembrolizumab works by binding to the protein PD-1 on the surface of certain immune cells called T cells, which keeps cancer cells from suppressing the immune system. This allows the …

TREATS 18 TYPES OF CANCER, INCLUDING CERTAIN EARLY-STAGE AND ADVANCED CANCERS ONE OF THOSE CANCERS IS EARLY-STAGE NON—SMALL CELL LUNG …

Keytruda (pembrolizumab) is a cancer chemotherapy drug that treats melanoma, lung cancer, and a host of other malignancies. It is often used in combination with other chemotherapy agents, …

2 days ago · KEYTRUDA, in combination with gemcitabine and cisplatin, is indicated for the treatment of patients with locally advanced unresectable or metastatic biliary tract cancer …

Mar 23, 2025 · What type of cancer does Keytruda treat particularly well? In clinical trials, the drug has demonstrated high efficacy in tumors with high tumor mutation burden (TMB), suggesting …

2 days ago · KEYTRUDA, in combination with enfortumab vedotin, as neoadjuvant treatment and then continued after cystectomy as adjuvant treatment, is indicated for the treatment of adult …

2 days ago · PADCEV plus Keytruda is the first and only regimen without platinum-based chemotherapy to improve event-free and overall survival when used before and after surgery …

Keytruda (generic name: pembrolizumab) is one of the most significant advancements in cancer treatment in the last decade. As a checkpoint inhibitor immunotherapy, Keytruda empowers …